Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure

Shock

Volumn 14, Issue 5, 2000, Pages 522-527

  Mitsuoka, Hiroshi ^a   Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell activation; Leukocytes; Microcirculation; Protease; Rat; Shock; Splanchnic arterial occlusion; Xanthine oxidase

Indexed keywords

ALLOPURINOL; GUANIDINE DERIVATIVE; NAFAMSTAT; PROTEINASE INHIBITOR; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL; ARTICLE; BILE; BLOOD PRESSURE; DRUG EFFECT; DUODENUM; INTESTINE MUCOSA; ISCHEMIA; LEUKOCYTE; MALE; METABOLISM; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SECRETION; VASCULARIZATION; WISTAR RAT;

ALLOPURINOL; ANIMALS; BILE; BLOOD PRESSURE; DUODENUM; GUANIDINES; INTESTINAL MUCOSA; ISCHEMIA; LEUKOCYTES; MALE; MULTIPLE ORGAN FAILURE; NEUTROPHILS; PROTEASE INHIBITORS; RATS; RATS, WISTAR; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

EID: 0034328248     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200014050-00005     Document Type: Article

References (37)

1. Mazzoni MC, Schmid-Schönbein GW: Mechanisms and consequences of cell activation in the microcirculation. Cardiovasc Res 32:709-719, 1996.
2. Yao YM, Redl H, Bahrami S, Schlag G: The inflammatory basis of trauma/ shock-associated multiple organ failure. Inflamm Res 47:201-210, 1998.
3. Barroso-Aranda J, Zweifach BW, Mathison JC, Schmid-Schönbein GW: Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock. J Cardiovasc Pharmacol 25(Suppl 2):s23-s29, 1995.
4. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [see comments]. Crit Care Med 20:864-874, 1992.
5. Huglund U, Lundgren O: Intestinal ischemia and shock factors. Fed Proc 37:2729-2733, 1978.
6. Schoenberg MH, Beger HG: Reperfusion injury after intestinal ischemia. Crit Care Med 21:1376-1386, 1993.
7. Rinaldo JE, Henson JE, Dauber JH, Henson PM: Role of alveolar macrophages in endotoxin-induced neutrophilic alveolitis in rats. Tissue Cell 17:461-472, 1985.
8. Palmer RM, Stepney RJ, Higgs GA, Eakins KE: Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species. Prostaglandins 20:411-418, 1980.
9. Camussi G, Bussolino F, Salvidio G, Baglioni C: Tumor necrosis factor/ cachectin stimulates peritoneal macrophages, polymorphonuclear leukocytes and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 166:1390-1394, 1987.
10. Lefer AM, Barenholz Y: Pancreatic hydrolases and the formation of a myocardial depressant factor in shock. Am J Physiol 223:1103-1109, 1972.
11. Mitsuoka H, Erik K, Schmid-Schönbein GW: Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes. Proc Natl Acad Sci USA 97:1772-1777, 2000.
12. Kooji A, Bosch KS, Frederiks WM, Van Noorden CJ: High levels of xanthine oxidoreductase in the rat endothelial, epithelial and connective tissue cells: a relation between localization and function? Virch Arch B Cell Pathol Mol Pathol 62:143-150, 1992.
13. Parks DA, Granger DN: Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals. Am J Physiol 245:G285-G289, 1983.
14. Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, Suzuki S, Fujita M: Pharmacological studies of FUT-175, nafamstat mesilate: I. Inhibition of protease activity in in vitro and in vivo experiments. Jap J Pharmacol 35:203-227, 1984.
15. Parks DA, Williams TK, Beckman JS: Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 17:G768-774, 1988.
16. Gossrau R, van Noordan CJF, Frederiks WM: Enhanced light microscopic visualization of oxidase activity with the cerine capture method. Histochemistry 92:349-353, 1989.
17. Kistler EB: Humoral Mechanisms of Cellular Activation in Ischemic Shock. PhD thesis. University of California, San Diego, CA, 1998.
18. Karwinski W, Husøy AM, Farstad M, Søreide O: Sixty minutes of normothermic ischemia in the rat liver: correlation between adenine nucleotides and bile excretion. J Surg Res 46:99-103, 1989.
19. Schierwagen C, Bylund-Fellenius AC, Lundberg C: Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 23:179-186, 1990.
20. Rappaport A: The microcirculatory acinar concept of normal and pathological hepatic structure. Beiträge zur Pathologie 157:215-243, 1976.
21. Amaya Y, Yamazaki K, Sato M, Noda K, Nishino TTN: Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. J Biol Chem 265:14170-14175, 1990.
22. Nagler L, Vartanyan L: Subunit structure of bovine milk xanthine oxidase: effect of limited cleavage by proteolytic enzymes on activity and structure. Biochem Biophys Acta 427:78-90, 1976.
23. Hotter G, Closa D, Prats N, Pi F, Gelpi E: Free radical enhancement promotes leukocyte recruitment through a PAF and LTB4 dependent mechanism. Free Radical Biol Med 22:947-954, 1996.
24. Della Corte E, Stirpe F: The regulation of rat liver xanthine oxidase: involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem J 126:739-745, 1972.
25. Granger DN, Rutili G, McCord JM: Role of superoxide radicals in intestinal ischemia. Gastroenterology 81:9-15, 1981.
26. McCord JM, Roy RS: The pathophysiology of superoxide: roles in inflammation and ischemia. Can J Physiol Pharmacol 60:1346-1352, 1982.
27. McKelvey TG, Hollwarth ME, Granger DN, Engerson TD, Lander U, Jones HP: Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol 254:G753-G760, 1988.
28. Saksela M, Lapatto R, Raivio KO: Irreversible conversion of xanthine dehydrogenase into xanthine oxidase by a mitochondrial protease. FEBS Lett 443:117-120, 1999.
29. Nilsson UA, Schoenberg MH, Åneman A, Poch B, Magadum S, Beger HG, Lundgren O: Free radicals and pathogenesis during ischemia and reperfusion of the cat small intestine. Gastroenterology 106:629-636, 1994.
30. Yasue N, Chan ET, Kaplowitz N, Guth PH: Effect of phorone and allopurinol on ischemia-reperfusion injury in gastrointestinal mucosa of the rat. Pharmacology 44:334-343, 1992.
31. Holloway CM, Harvey PR, Mullen JB, Strasberg SM: Evidence that cold preservation-induced microcirculatory injury in liver allografts is not mediated by oxygen-free radicals or cell swelling in the rat. Transplantation 48:179-188, 1989.
32. Yasue N, Guth PH: Role of exogenous acid and retransfusion in hemorrhagic shock-induced gastric lesions in the rat. Gastroenterology 94:1135-1143, 1988.
33. Sofianos A: A Partial Characterization of Pancreatic Activating Factors. MS thesis. University of California, San Diego, CA, 1999.
34. Kistler EB, Sofianos A, Schmid-Schönbein GW, Hugli TE: A partial characterization of neutrophil activating factors from porcine pancreas. FASEB J 13:758, 1999.
35. Schoenberg MH, Poch B, Younes M, Schwarz A, Baczako K, Lundberg C, Haglund U, Beger HG: Involvement of neutrophils in postischaemic damage to the small intestine. Gut 32:905-912, 1991.
36. Kistler EB, Hugli T, Schmid-Schönbein GW: The pancreas as a source of cardiovascular cell activating factors. Microcirculation 7:183-192, 2000.
37. Kistler EB, Lefer AM, Hugli TE, Schmid-Schönbein GW: Plasma activation during splanchnic arterial occlusion shock. Shock 14:30-34, 2000.